Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.67 USD
Change Today +0.39 / 2.73%
Volume 1.1M
FOLD On Other Exchanges
As of 3:03 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John F. Crowley

Chairman and Chief Executive officer,Amicus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 4 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John F. Crowley has been the Chairman at Amicus Therapeutics, Inc. since August 15, 2011 and also its Chief Executive Officer since August 15, 2011. Mr. Crowley served as the Chief Executive Officer of Amicus Therapeutics Inc. from January 2005 to April 2011. Mr. Crowley founded Orexigen Therapeutics and served as its President & Chief Executive Officer from September 2003 to January 2005. Mr. Crowley served as the President of Amicus Therapeutics Inc. from January ...

Read Full Background

Corporate Headquarters*

1 Cedar Brook Drive
Cranbury, New Jersey 08512

United States

Phone: 609-662-2000
Fax: 609-662-2001

Board Members Memberships*

Chairman and Chief Executive officer


MBA 1997
Harvard Business School
BS 1989
Georgetown University
JD 1992
Notre Dame Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,083,405

Stock Options*

All Other Compensation$815,445
Exercised Options89,000
Exercised Options Value$269,981
Exercisable Options1,371,893
Exercisable Options Value$3,348,468
Unexercisable Options736,107
Unexercisable Options Value$3,454,617
Total Value of Options$7,073,066
Total Number of Options2,197,000

Total Compensation*

Total Annual Cash Compensation$1,898,850
Total Short Term Compensation$1,083,405
Other Long Term Compensation$815,445
Total Calculated Compensation$2,750,480
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $14.67 USD +0.39


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at